Dalibor Sames

13PUBLICATIONS
42CO-AUTHORS
Biologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Circuits and systemsCharacterisation of biological macromoleculesSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 10, 2026
Oxa-noribogaine reduces alcohol drinking through aversion learning and by altering glutamatergic activity in the mPFC.

Marcus Meinhardt, Ivan Skorodumov, Florian Walter

|Dec 26, 2025
Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses.

Christopher Hwu, Václav Havel, Xavier Westergaard

|Feb 13, 2025
Seeing the Spikes: The Future of Targetable Synthetic Voltage Sensors.

Tomas Fiala, David Sulzer, Dalibor Sames

|Sep 20, 2024
Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models.

Václav Havel, Andrew C Kruegel, Benjamin Bechand

|May 08, 2024
Structural pharmacology and therapeutic potential of 5-methoxytryptamines.

Audrey L Warren, David Lankri, Michael J Cunningham

|Apr 01, 2024
Molecular Design of SERTlight: A Fluorescent Serotonin Probe for Neuronal Labeling in the Brain.

Wei-Li Lee, Xavier Westergaard, Christopher Hwu

Pageof 3